JP2009505633A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009505633A5 JP2009505633A5 JP2008503299A JP2008503299A JP2009505633A5 JP 2009505633 A5 JP2009505633 A5 JP 2009505633A5 JP 2008503299 A JP2008503299 A JP 2008503299A JP 2008503299 A JP2008503299 A JP 2008503299A JP 2009505633 A5 JP2009505633 A5 JP 2009505633A5
- Authority
- JP
- Japan
- Prior art keywords
- kntc2
- seq
- cdca1
- double
- stranded molecule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 101001112162 Homo sapiens Kinetochore protein NDC80 homolog Proteins 0.000 claims 20
- 102100023890 Kinetochore protein NDC80 homolog Human genes 0.000 claims 19
- 101000590482 Homo sapiens Kinetochore protein Nuf2 Proteins 0.000 claims 15
- 102100032431 Kinetochore protein Nuf2 Human genes 0.000 claims 15
- 239000002773 nucleotide Substances 0.000 claims 15
- 125000003729 nucleotide group Chemical group 0.000 claims 15
- 108091081021 Sense strand Proteins 0.000 claims 10
- 229920001184 polypeptide Polymers 0.000 claims 10
- 102000004196 processed proteins & peptides Human genes 0.000 claims 10
- 108090000765 processed proteins & peptides Proteins 0.000 claims 10
- 125000003275 alpha amino acid group Chemical group 0.000 claims 9
- 230000000692 anti-sense effect Effects 0.000 claims 8
- 238000000034 method Methods 0.000 claims 8
- 208000002154 non-small cell lung carcinoma Diseases 0.000 claims 6
- 108091034117 Oligonucleotide Proteins 0.000 claims 5
- 230000014509 gene expression Effects 0.000 claims 5
- 108091028664 Ribonucleotide Proteins 0.000 claims 4
- 150000001875 compounds Chemical class 0.000 claims 4
- 108090000623 proteins and genes Proteins 0.000 claims 4
- 102000004169 proteins and genes Human genes 0.000 claims 4
- 239000002336 ribonucleotide Substances 0.000 claims 4
- 125000002652 ribonucleotide group Chemical group 0.000 claims 4
- 239000003153 chemical reaction reagent Substances 0.000 claims 3
- 230000000295 complement effect Effects 0.000 claims 3
- 238000004393 prognosis Methods 0.000 claims 3
- 108020004459 Small interfering RNA Proteins 0.000 claims 2
- 230000004071 biological effect Effects 0.000 claims 2
- 108020004999 messenger RNA Proteins 0.000 claims 2
- 108020004707 nucleic acids Proteins 0.000 claims 2
- 102000039446 nucleic acids Human genes 0.000 claims 2
- 150000007523 nucleic acids Chemical class 0.000 claims 2
- 108091033319 polynucleotide Proteins 0.000 claims 2
- 239000002157 polynucleotide Substances 0.000 claims 2
- 102000040430 polynucleotide Human genes 0.000 claims 2
- 238000012216 screening Methods 0.000 claims 2
- 238000010837 poor prognosis Methods 0.000 claims 1
- 108700026220 vif Genes Proteins 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US70370405P | 2005-07-29 | 2005-07-29 | |
| US60/703,704 | 2005-07-29 | ||
| PCT/JP2006/314715 WO2007013480A2 (en) | 2005-07-29 | 2006-07-19 | Screening and therapeutic method for nsclc targeting cdca1-kntc2 complex |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009505633A JP2009505633A (ja) | 2009-02-12 |
| JP2009505633A5 true JP2009505633A5 (enExample) | 2009-09-10 |
| JP5150855B2 JP5150855B2 (ja) | 2013-02-27 |
Family
ID=37434044
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008503299A Expired - Fee Related JP5150855B2 (ja) | 2005-07-29 | 2006-07-19 | Ｃｄｃａ１−ｋｎｔｃ２複合体を標的とするスクリーニングおよびｎｓｃｌｃの治療方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US7943295B2 (enExample) |
| EP (1) | EP1915622A2 (enExample) |
| JP (1) | JP5150855B2 (enExample) |
| CN (1) | CN101283279A (enExample) |
| WO (1) | WO2007013480A2 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008120812A1 (en) * | 2007-03-30 | 2008-10-09 | Oncotherapy Science, Inc. | Screening and therapeutic method for nsclc targeting the cdca8-aurkb complex |
| ES2537323T3 (es) | 2007-08-20 | 2015-06-05 | Oncotherapy Science, Inc. | Péptido CDCA1 y agente farmacéutico que lo comprende |
| GB0719367D0 (en) | 2007-10-03 | 2007-11-14 | Procarta Biosystems Ltd | Transcription factor decoys, compositions and methods |
| TWI526219B (zh) * | 2008-06-19 | 2016-03-21 | 腫瘤療法 科學股份有限公司 | Ｃｄｃａ１抗原決定位胜肽及含此胜肽的疫苗 |
| TW201008574A (en) | 2008-08-19 | 2010-03-01 | Oncotherapy Science Inc | INHBB epitope peptides and vaccines containing the same |
| GB201002413D0 (en) | 2010-02-12 | 2010-03-31 | Procarta Biosystems Ltd | Nucleic acid complexes |
| GB201005545D0 (en) | 2010-04-01 | 2010-05-19 | Procarta Biosystems Ltd | Transcription factor decoys |
| EP2872532A4 (en) | 2012-07-10 | 2016-04-13 | Oncotherapy Science Inc | CDCA1-EPITOPPEPTIDES FOR TH1 CELLS AND VACCINES THEREWITH |
| TWI658049B (zh) | 2013-03-12 | 2019-05-01 | 腫瘤療法 科學股份有限公司 | Ｋｎｔｃ２胜肽及含此胜肽之疫苗 |
| JP6700512B2 (ja) * | 2014-08-04 | 2020-05-27 | オンコセラピー・サイエンス株式会社 | Ｃｄｃａ１由来ペプチドおよびそれを含むワクチン |
| TW202023581A (zh) | 2018-08-02 | 2020-07-01 | 日商腫瘤療法 科學股份有限公司 | 來自cdca1的胜肽及含有此的疫苗 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020172952A1 (en) * | 1999-06-30 | 2002-11-21 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
| EP1196565A2 (en) * | 1999-06-30 | 2002-04-17 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
| US20030211510A1 (en) * | 1999-06-30 | 2003-11-13 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
| AR031250A1 (es) * | 2000-07-11 | 2003-09-17 | Corixa Corp | Composiciones y metodos para la terapia y el diagnostico del cancer de pulmon |
| WO2003077875A2 (en) * | 2002-03-15 | 2003-09-25 | Incyte Corporation | Proteins associated with growth, differentiation, and death |
| EP2267023B1 (en) | 2002-09-12 | 2015-02-11 | Oncotherapy Science, Inc. | KDR peptides and vaccines comprising the same |
| US20060024692A1 (en) * | 2002-09-30 | 2006-02-02 | Oncotherapy Science, Inc. | Method for diagnosing non-small cell lung cancers |
| CA2500687A1 (en) * | 2002-10-02 | 2004-04-15 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
| GB0306085D0 (en) * | 2002-12-04 | 2003-04-23 | Unilever Plc | Improved composition for topical application |
| US20040224408A1 (en) | 2002-12-10 | 2004-11-11 | Jean-Philippe Girard | THAP proteins as nuclear receptors for chemokines and roles in transcriptional regulation, cell proliferation and cell differentiation |
| EP1583820A4 (en) * | 2003-01-14 | 2007-07-18 | Bristol Myers Squibb Co | ASSOCIATED POLYNUCLEOTIDES AND POLYPEPTIDES ASSOCIATED WITH THE NF-KB WAY |
| CA2522299A1 (en) * | 2003-04-15 | 2004-10-28 | Avalon Pharmaceuticals, Inc | Determining cancer-linked genes and therapeutic targets using molecular cytogenetic methods |
| US7339051B2 (en) * | 2003-04-28 | 2008-03-04 | Isis Pharmaceuticals, Inc. | Compositions and methods for the treatment of severe acute respiratory syndrome (SARS) |
| WO2005019258A2 (en) | 2003-08-11 | 2005-03-03 | Genentech, Inc. | Compositions and methods for the treatment of immune related diseases |
| EP2495324B1 (en) * | 2004-04-09 | 2015-03-04 | Genecare Research Institute Co., Ltd | Cancer cell-specific apoptosis-inducing agents that target chromosome stabilization-associated genes |
| WO2006110264A2 (en) * | 2005-03-16 | 2006-10-19 | Sidney Kimmel Cancer Center | Methods and compositions for predicting death from cancer and prostate cancer survival using gene expression signatures |
| ES2537323T3 (es) | 2007-08-20 | 2015-06-05 | Oncotherapy Science, Inc. | Péptido CDCA1 y agente farmacéutico que lo comprende |
-
2006
- 2006-07-19 WO PCT/JP2006/314715 patent/WO2007013480A2/en not_active Ceased
- 2006-07-19 CN CNA200680035270XA patent/CN101283279A/zh active Pending
- 2006-07-19 EP EP06781627A patent/EP1915622A2/en not_active Withdrawn
- 2006-07-19 JP JP2008503299A patent/JP5150855B2/ja not_active Expired - Fee Related
- 2006-07-19 US US11/913,142 patent/US7943295B2/en not_active Expired - Fee Related
-
2011
- 2011-04-05 US US13/080,461 patent/US20110263012A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009502115A5 (enExample) | ||
| JP2012135301A5 (enExample) | ||
| JP2008532477A5 (enExample) | ||
| JP2006500949A5 (enExample) | ||
| US10705087B2 (en) | Detection method for NTRK3 fusion | |
| JP2007506426A5 (enExample) | ||
| JP2009502116A5 (enExample) | ||
| JP2012501164A5 (enExample) | ||
| WO2008052774A3 (en) | Methods for detection of a single- or double-stranded nucleic acid molecule | |
| JP2006500948A5 (enExample) | ||
| EP3543359B1 (en) | Molecular marker, kit and application for use in early diagnosis and prediction of sepsis as complication of acute kidney injury | |
| AU2003293124A1 (en) | Heart failure gene determination and therapeutic screening | |
| JP2011514162A (ja) | 炎症性腸疾患および過敏性腸症候群のバイオマーカー | |
| KR20190089552A (ko) | 비근침윤성 방광암 진단용 바이오마커 및 이의 용도 | |
| JP2005537007A5 (enExample) | ||
| CN106319031A (zh) | 反复自然流产相关微小rna及其应用 | |
| JP2008512984A5 (enExample) | ||
| JPWO2019208671A5 (enExample) | ||
| JP2005511023A5 (enExample) | ||
| JP2010523081A5 (enExample) | ||
| KR20110015013A (ko) | 결장직장암의 평가 방법 및 여기에 사용하기 위한 조성물 | |
| JP2014523736A5 (enExample) | ||
| KR101929009B1 (ko) | 뇌졸중 진단용 조성물 및 이를 진단하는 방법 | |
| RU2011111551A (ru) | C12orf48 как ген-мишень для лечения и диагностики рака | |
| WO2020175898A1 (ko) | Tut4/7 발현 조절인자를 포함하는 암 예방 또는 치료용 약학적 조성물 |